Home

Andrew Arno

CIK 1472122 · last filed 2026-07-06

Andrew Arno is a corporate insider who has filed 61 SEC Form 4 insider transactions across 6 companies since 2015. The most recent filing shows the insider had shares withheld for taxes covering $68.8K of OCX on Jul 6, 2026. Across all open-market trades the lifetime net is +$618.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $50.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$50.6K

Companies

6

Total Filings

61

Lifetime Open-Market Net

$618.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Insight Molecular Diagnostics Inc. (OCX) Delisted Director 164,589 $3.20 $526.7K $480.0K 22 2026-07-06
VTAK Director — $0.28 — $0 3 2026-03-30
SMSI Director 17,976 $2.80 $50.3K $99.5K 19 2026-03-10
XXII Director 58 $4.41 $256 $17.5K 3 2025-11-14
Asterias Biotherapeutics, Inc. (AST) Delisted Director 5,000 — — $21.6K 4 2018-06-25
Asterias Biotherapeutics, Inc. (AST.WS) Delisted Director — — — $0 1 2017-04-03

Recent Filings

61 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-06 Insight Molecular Diagnostics Inc. (OCX) Delisted Tax (F) −12,100 -$68.8K EDGAR
2026-06-15 Insight Molecular Diagnostics Inc. (OCX) Delisted Grant (A) +32,331 $0 EDGAR
2026-03-30 VTAK Grant (A) — $0 EDGAR
2026-03-10 SMSI Grant (A) +12,500 $0 EDGAR
2025-11-14 XXII Grant (A) +17,295 $0 EDGAR
2025-10-29 SMSI Grant (A) +7,993 $0 EDGAR
2025-08-14 VTAK Grant (A) — $0 EDGAR
2025-07-03 Insight Molecular Diagnostics Inc. (OCX) Delisted Grant (A) +55,000 $0 EDGAR
2025-03-12 XXII Grant (A) +4,237 $0 EDGAR
2025-01-31 VTAK Grant (A) — $0 EDGAR
Showing 1–10 of 61
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.